期刊文献+

厄贝沙坦在高血压合并糖尿病患者治疗中的应用价值

暂未订购
导出
摘要 目的探讨厄贝沙坦在高血压合并糖尿病患者治疗中的应用价值。方法选取甘肃省酒泉市人民医院收治的80例高血压合并糖尿病患者,采用随机掷硬币法分为对照组和观察组,每组40例。对照组给予常规控制血压、血糖治疗,观察组联合厄贝沙坦治疗。于入院当天(治疗前)和治疗12个月后(治疗后)比较两组治疗前后血压变异性指标和靶器官损伤情况。结果治疗后,两组24 h收缩压(SBP)、24 h舒张压(DBP)、24 h收缩压标准差(SSD)和24 h舒张压标准差(DSD)均较治疗前明显改善,差异有统计学意义(P<0.05);且观察组均低于对照组,差异有统计学意义(P<0.05)。治疗后,观察组左心室肥厚、肾功损害、脑损害、存在靶器官损害发生率均低于对照组,差异有统计学意义(P<0.05)。结论在常规治疗基础上联合厄贝沙坦能改善高血压合并糖尿病患者血压变异性,减轻靶器官损伤。
出处 《现代医学与健康研究电子杂志》 2019年第12期12-13,共2页 Modern Medicine and Health Research
  • 相关文献

二级参考文献61

  • 1王志华,初少莉,陈绍行,杜俭,陆旭辉,钱文琪,吴顺娣,郭冀珍,朱鼎良.高血压住院患者病因及危险因素分析[J].高血压杂志,2005,13(8):504-509. 被引量:83
  • 2潘永寿,郭盛兰.超声心动图测定左室心肌重量的研究[J].广西医科大学学报,2005,22(6):986-988. 被引量:2
  • 3黄晓新,谢云,谷利宏.262例高血压患者心脏结构变化的研究[J].实用医技杂志,2006,13(17):3044-3045. 被引量:4
  • 4Baszczuk A, Kopczyr:ski Z, Thielemann A. Endothelial dys function in patients with primary hypertension and hyperho- mocysteinemia. Postepy Hig Med Dosw (Online),2014,68: 91-100.
  • 5Cheng X. Updating the relationship between hyperhomocys- teinemia lowering therapy and cardiovascular events. Cardio- vasc Ther,2013,31: e19-e26.
  • 6Grassi G, Bombelli M, Brambilla G, et al. Total cardiovascular risk,blood pressure variability and adrenergic overdrive in hy pertension: evidence, mechanisms and clinical implications. Curr Hypertens Rep,2012,14:333 338.
  • 7Onishi A, Morishita Y, Watanabe M, et al. Action of irbesar tan on blood pressure and glucose/lipid metabolism,in hemo dialysis patients with hypertension. Int J Gen Med, 2013,6 405-411.
  • 8Szel6nyi Z, Fazakas A, Szendsi G, et al. The mechanism ol reducedlongitudinal left ventricular systoHc function in hypertensivepatients with normal ejection frac;tion[J]. J Hypertens, 2015, 33(9):1962-1969.
  • 9Kereiakes DJ, Chrysant SG, Izzo JL, et al. Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertensionand diabetes, chronic kidney disease, or chronic cardiovasculardisease: a subanalysis of the multicenter, randomized,double-blind, parallel-group TRINITY study [J]. CardiovascDiabetol, 2012, 11:134.
  • 10Fogari R, Derosa G, Zoppi A, et al. Comparative effect ofcanrenone or hydrochlorothiazide addition to valsartan/amlodipinecombination on urinary albumin excretion in well-controlled type2 diabetic hypertensive patients with microalbuminuria[J]. ExpertOpin Pharmacother, 2014,15(4):453-459.

共引文献120

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部